Correspondence: Christina Ehrhardt: ehrhardc@uni-muenster.de Figure S1 . Determination of the effective concentration 50% (EC 50 ) of Vemurafenib. A549 cells were infected with 0.01 MOI (A) H7N7 (SC35M) or (B) H7N9 (A/Anhui). Cells were subsequently treated with different concentrations of Vemurafenib (0-25 µM). Progeny virus particles in the supernatant were measured by standard plaque assay 24 hpi. The EC50 values were calculated from three independent experiments with GraphPad Prism 5 software and depicted as mean (± SEM).
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